Cutaneous Adverse Reactions of Anticancer Agents

被引：14
作者：
Kaul, Subuhi [1 ]
Kaffenberger, Benjamin H. [2 ]
Choi, Jennifer N. [3 ]
Kwatra, Shawn G. [4 ]
机构：
[1] All India Inst Med Sci, Dept Dermatol, New Delhi 110029, India
[2] Ohio State Dermatol, 1328 Dublin Rd,Suite 100, Columbus, OH 43212 USA
[3] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Dept Dermatol,Div Oncodermatol, 676 North St Clair,Suite 1600, Chicago, IL 60611 USA
[4] Johns Hopkins Univ, Sch Med, 1550 Orleans St,CRB 2 Suite 206, Baltimore, MD 21231 USA
来源：
DERMATOLOGIC CLINICS | 2019年 / 37卷 / 04期
关键词：
Skin; Drugs; Cutaneous adverse effects; Anticancer; Chemotherapy; Immunotherapy; HAND-FOOT-SYNDROME; NEUTROPHILIC ECCRINE HIDRADENITIS; PEGYLATED LIPOSOMAL DOXORUBICIN; BREAST-CANCER PATIENTS; TARGETED THERAPIES; CLINICAL PRESENTATION; SKIN REACTIONS; SINGLE-CENTER; CHEMOTHERAPY; INHIBITORS;
D O I：
10.1016/j.det.2019.05.013
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Cutaneous adverse effects are one of the most frequently observed adverse reactions with anticancer agents. This has only intensified with newer targeted and immunologic agents that present with a wide array of drug toxicities and skin reactions. The spectrum ranges from benign, localized dermatoses to generalized, life-threatening cutaneous toxicities. Herein, the authors review the cutaneous adverse effects observed with conventional chemotherapy as well as targeted agents, including the emerging immune checkpoint inhibitors, which have been revolutionary in the treatment of many malignancies.
引用
收藏
页码：555 / +
页数：15
相关论文
共 79 条
  • [1] Syringometaplasia: variants and underlying mechanisms
    Abbas, Ossama
    Bhawan, Jag
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2016, 55 (02) : 142 - 148
  • [2] Search for Evidence-Based Approaches for the Prevention and Palliation of Hand-Foot Skin Reaction (HFSR) Caused by the Multikinase Inhibitors (MKIs)
    Anderson, Roger
    Jatoi, Aminah
    Robert, Caroline
    Wood, Laura S.
    Keating, Karen N.
    Lacouture, Mario E.
    [J]. ONCOLOGIST, 2009, 14 (03) : 291 - 302
  • [3] Baran R, 2012, BARAN DAWBERS DIS NA, P413
  • [4] Rapid Drug Desensitization with Biologics: A Single-Center Experience writh Four Biologics
    Bavbek, Sevim
    Kendirlinan, Resat
    Cerci, Pamir
    Altiner, Seda
    Soyyigit, Sadan
    Sozener, Zeynep Celebi
    Aydin, Omur
    Gumusburun, Reyhan
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2016, 171 (3-4) : 227 - 233
  • [5] Incidence and risk of hand-foot skin reaction with cabozantinib, a novel multikinase inhibitor: a meta-analysis
    Belum, V. R.
    Serna-Tamayo, C.
    Wu, S.
    Lacouture, M. E.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2016, 41 (01) : 8 - 15
  • [6] Toxic erythema of chemotherapy: A useful clinical term
    Bolognia, Jean L.
    Cooper, Dennis L.
    Glusac, Earl J.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 59 (03) : 524 - 529
  • [7] Neutrophilic hidradenitis induced by chemotherapy involves eccrine and apocrine glands
    Brehler, R
    Reimann, S
    Bonsmann, G
    Metze, D
    [J]. AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1997, 19 (01) : 73 - 78
  • [8] Symptom management: the utility of regional cooling for hand-foot syndrome induced by pegylated liposomal doxorubicin in ovarian cancer
    Bun, Seiko
    Yunokawa, Mayu
    Tamaki, Yoshiko
    Shimomura, Akihiko
    Shimoi, Tatsunori
    Kodaira, Makoto
    Shimizu, Chikako
    Yonemori, Kan
    Fujiwara, Yasuhiro
    Makino, Yoshinori
    Terakado, Hiroyuki
    Tamura, Kenji
    [J]. SUPPORTIVE CARE IN CANCER, 2018, 26 (07) : 2161 - 2166
  • [9] Rapid Desensitization of Hypersensitivity Reactions to Chemotherapy Agents
    Castells, Mariana
    [J]. CURRENT DRUG SAFETY, 2006, 1 (03) : 243 - 251
  • [10] Anaphylaxis to Chemotherapy and Monoclonal Antibodies
    Castells, Mariana C.
    [J]. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2015, 35 (02) : 335 - +
12345678